Jon A. Olson
Analyst · Nomura System
Thank you, Rick. Fiscal year 2012 was marked by challenging industry conditions. In spite of these, Xilinx introduced a record number of 28-nanometer products, gained market share on the 40-nanometer node and reported record operating cash flow of $827 million. Additionally, cost reduction efforts of the company contributed to gross margin improvement in each consecutive quarter of the year, enabling Xilinx to report a record gross margin of 66.4% in the March quarter. Turning to the March quarter, Xilinx sales were $559 million, up 9% sequentially and down 5% from the same quarter a year ago. This was better than our guidance heading into the quarter, primarily due to better-than-expected business from wireless communications customers deploying LTE and 3D technology, as well as a strong rebound across-the-board in the Industrial and Other category. Consumer & Automotive also posted better-than-expected strength due to exceptionally strong Automotive business across a broad base of customers and a better-than-expected growth from audio and video broadcast. Gross margin was a record of 66.4%, up from 65.8% in the prior quarter, driven in part by a more favorable customer and product mix, but also cost reduction efforts driven by the company, including better-than-expected yield improvement on newer products and better inventory supply chain management. Operating expenses were $208 million, only $1 million dollars higher than guided, as we were able to offset higher variable with expense management efforts. Operating margin was 29.1%, up from 26.8% in the prior quarter. New product sales were up 11% sequentially. Sales increases from our 28-, 40-, 45-nanometer and 65-nanometer products, all contributed to this increase. Mainstream products declined 4% and base products increased 21% sequentially or $24 million. The increase associated with last time buy products was about $18 million or approximately 3% of total revenue in Q4. Let me now turn to a discussion of end markets. Communication sales increased 5% sequentially, driven by wireless sales, which increased double-digits during the quarter while wired sales were essentially flat. The Industrial and Other category posted the strongest sequential sales growth during the quarter, increasing 18% sequentially, with all secondary markets increasing double-digits. Consumer & Automotive sales increased 9% sequentially driven by strength from audio/video broadcast and automotive, while pure-play consumer applications were flat. Lastly, data processing sales decreased as anticipated, driven by weaker storage sales. Net income for the quarter was $134 million or $0.49 per diluted share. Other income and expense was a net expense of $7.1 million, better than guided due primarily to higher-than-anticipated gains associated with our investment portfolio and a non-U.S. investment credit. Operating cash flow for the March quarter was $208 million before $20 million in CapEx. We paid $50 million in cash dividend during the quarter, and recently raised our quarterly dividend $0.03 per share to 22% -- $0.22 per share per quarter. The tax rate in the March quarter was 14%. Diluted shares for the quarter were 276 million. There was a 7.7 million share dilutive effect from our convertible notes due to an increase in the average stock price during the quarter. For questions related to the dilution associated with our convertibles, please visit our Investor Relations website at www.investor.xilinx.com. Let me now comment on the balance sheet. Cash and investments increased $175 million to approximately $3.1 billion. We have approximately $1.3 billion in convertible debt and our net cash position is approximately $1.8 billion. Days sales outstanding decreased 3 days in the March quarter to 35 days. Inventory dollars at Xilinx declined by $41 million sequentially during the quarter. Combined inventory days at Xilinx, distribution were 110, down significantly as expected from 142 days in the prior quarter. In the June quarter, we expect both dollars and days of inventory to slightly decline as we continue to align the appropriate supply with demand trend. Let me now turn to a discussion of guidance for the June quarter of fiscal year '13. Our backlog heading into the quarter is up sequentially. We are expecting strong growth from our 28-nanometer and 40-, 45-nanometer product families. From an end market perspective, we are expecting sales from Communications to be up sequentially, with increases in both wired and wireless. We expect sales from Industrial and Other to be approximately flat sequentially, as increases in industrial, scientific and medical are offset by a decrease from defense. Consumer & Automotive is expected to be approximately flat, as increases in automotive are offset by a decrease in audio/video broadcast. Lastly, we expect data processing sales to increase sequentially. We expect last time buy sales to decline by about $5 million sequentially. As a result, we are expecting total sales to be up 1% to up 5% sequentially, with sales from Asia Pacific expected to increase, sales from Europe expected to be approximately flat and sales from the U.S. and Japan expected to be down. And the midpoint of our sales guidance is predicated on a turns rate of approximately 55%. Gross margin is expected to be between 65% and 66%, slightly lower than the March quarter due to strong growth expectations from our 40-, 45-nanometer and 28-nanometer products. Operating expenses in the June quarter are expected to be approximately $220 million, including approximately $2 million of amortization of acquisition-related intangibles. The majority of the growth in spending compared with the March quarter is in R&D and related to the 28-nanometer ramp, as our tape-out activity remains high. There's also some growth in our SG&A related primarily to variable spending increases as a result of higher revenue and also higher legal expenses. Other income and expense is expected to be a net expense of approximately $8 million. The share count is expected to be approximately 277 million shares. The tax rate is expected to be approximately 16%. This number excludes the impact of the R&D tax credit which has expired. Our estimate of the impact if reinstated in its current form, would lower the tax rate by approximately 1.5%. Let me now let me now turn the call over to Moshe.